These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2873599)

  • 21. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of propranolol and carvedilol in urine samples using a magnetic polyamide composite and LC-MS/MS.
    Ballesteros-Esteban T; Reyes-Gallardo EM; Lucena R; Cárdenas S; Valcárcel M
    Bioanalysis; 2016 Oct; 8(20):2115-23. PubMed ID: 27593542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of beta-adrenoblockers on prostaglandin-induced ocular hypertension in rabbits].
    Ermakova VN
    Biull Eksp Biol Med; 1983 Oct; 96(10):64-6. PubMed ID: 6138108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

  • 25. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of penbutolol on the hemodynamics in patients with hypertensive disease].
    Demin AA; Mitrokhin VE
    Farmakol Toksikol; 1986; 49(5):74-6. PubMed ID: 3770181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlations between subjective compliance, objective compliance, and factors determining compliance in geriatric hypertensive patients treated with triamterene and hydrochlorothiazide.
    Oelzner S; Brandstädt A; Hoffmann A
    Int J Clin Pharmacol Ther; 1996 Jun; 34(6):236-42. PubMed ID: 8793610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of anaprilin on cardiac hemodynamic indices in elderly hypertensive patients].
    Severova NL
    Vrach Delo; 1983 May; (5):26-30. PubMed ID: 6136127
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta-blockers and arterial hypertension: comparison between nadolol and propranolol].
    Abate G; Polimeni RM; Di Peppe MC; Guarino F; Troja C; Marisi F; Cerritelli E; Brillante C; De Angelis M
    Clin Ter; 1982 Aug; 102(3):283-291. PubMed ID: 7140182
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative evaluation of the therapeutic effect of various classes of beta-blockaders in patients with hypertension].
    Erina EV; Charyev KhE
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):26-34. PubMed ID: 6139117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug lowering of the HDL concentration in the serum of cardiologically treated patients].
    Köhler P; Baufeld H; Stöckel A; Ziegenhorn A
    Z Gesamte Inn Med; 1982 Oct; 37(19):654-8. PubMed ID: 6129752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relaxation and rapid filling of the left ventricle in essential hypertension during treatment with a non-selective beta blocker].
    Sirakova V; Penkov N; Kaponov Kh
    Vutr Boles; 1987; 26(3):33-8. PubMed ID: 2887071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of beta adrenergic receptor blockaders in industrial workers with neurocirculatory asthenia of the hypertensive type].
    Maziĭ SA; Senik EA; Turashvili GA; Zisel'man SB; Kazarian AB
    Sov Med; 1988; (7):96-9. PubMed ID: 3067385
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical study of a new beta-adrenergic receptor blocking substance, indenolol].
    Cirino D; Savonelli C; Maggi GC
    Minerva Cardioangiol; 1983 Nov; 31(11):671-6. PubMed ID: 6142433
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of beta-blocking agents talinolol and metipranolol in patients with thyrotoxicosis (author's transl)].
    Nedvídková J; Cenková V; Felt V
    Cas Lek Cesk; 1980 Jul; 119(27-28):749-51. PubMed ID: 6107177
    [No Abstract]   [Full Text] [Related]  

  • 37. Bopindolol, a new long-acting beta-adrenoceptor antagonist--a randomized comparison against propranolol in hypertensive patients.
    Kirch W; Axthelm T
    Int J Clin Pharmacol Res; 1983; 3(2):89-93. PubMed ID: 6148312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined use of talinolol and beta adrenergic stimulants in status asthmaticus. Report on 3 patients].
    Oltmanns G; Schwela H; Szeszat S; Knappe J
    Z Erkr Atmungsorgane; 1984; 163(3):297-303. PubMed ID: 6152092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Acute effects of beta receptor blockaders in hyperthyroidism].
    Váradi A; Földes J; Gyertyánffy G; Borvendég J; Brüll J
    Orv Hetil; 1981 May; 122(18):1069-72. PubMed ID: 6115351
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
    Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
    Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.